vitrasert

Frequently asked questions

What does Vitrasert treat?

Vitrasert (Ganciclovir) may be used to treat AIDS-related opportunistic infections, cytomegalovirus retinitis, based on NIH RxClass drug-classification data (conditions a drug may treat — not a verbatim copy of the FDA-approved label). This is general reference, not medical advice.

Is there a coupon or discount for Vitrasert?

pharmaranks is an independent ratings site, not a pharmacy — we don't issue coupons or sell Vitrasert. To pay less, ask your prescriber or pharmacist whether a generic equivalent exists, check the manufacturer's copay/savings card and patient-assistance program, and compare a pharmacy discount card against your insurance copay. Prices vary by pharmacy, insurance, and location, so always confirm at the counter. This is general reference, not medical or financial advice.

Who makes Vitrasert?

Vitrasert is marketed by Bausch and Lomb. You can see Bausch and Lomb's full profile, rating, and other products on pharmaranks.

Is Vitrasert a brand-name or generic drug?

Vitrasert is a brand-name product with the active ingredient Ganciclovir.

Is Vitrasert available over the counter?

No. Vitrasert is a prescription (Rx) medication in the US — you need a prescription from a licensed clinician (in person or via telehealth); it isn't sold over the counter. For some conditions there are OTC alternatives — ask your pharmacist.

What forms does Vitrasert come in?

Vitrasert is currently marketed as implant, per the FDA's National Drug Code Directory.

What class of drug is Vitrasert?

Vitrasert is classified as cytomegalovirus nucleoside analog dna polymerase inhibitor, nucleoside analog antiviral, per the FDA's Established Pharmacologic Class.

Is Vitrasert FDA-registered?

Vitrasert is on record with the U.S. FDA under application number NDA020569. You can verify this on its official FDA label.